These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 26815934)
1. The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study. Eriksson H; Lyth J; Andersson TM Int J Cancer; 2016 Jun; 138(12):2829-36. PubMed ID: 26815934 [TBL] [Abstract][Full Text] [Related]
2. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study. Andersson TM; Eriksson H; Hansson J; Månsson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC Cancer Epidemiol; 2014 Feb; 38(1):93-9. PubMed ID: 24447700 [TBL] [Abstract][Full Text] [Related]
3. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men. Lyth J; Eriksson H; Hansson J; Ingvar C; Jansson M; Lapins J; Månsson-Brahme E; Naredi P; Stierner U; Ullenhag G; Carstensen J; Lindholm C Br J Dermatol; 2015 Mar; 172(3):700-6. PubMed ID: 25323770 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study. Eriksson H; Frohm-Nilsson M; Järås J; Kanter-Lewensohn L; Kjellman P; Månsson-Brahme E; Vassilaki I; Hansson J Br J Dermatol; 2015 Jan; 172(1):175-86. PubMed ID: 24910143 [TBL] [Abstract][Full Text] [Related]
5. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden. Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J J Clin Oncol; 2014 May; 32(13):1356-64. PubMed ID: 24687828 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden. Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457 [TBL] [Abstract][Full Text] [Related]
7. Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register. Lyth J; Mikiver R; Nielsen K; Isaksson K; Ingvar C Eur J Cancer; 2016 May; 59():171-178. PubMed ID: 27046697 [TBL] [Abstract][Full Text] [Related]
8. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden. Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous malignant melanoma show geographic and socioeconomic disparities in stage at diagnosis and excess mortality. Strömberg U; Peterson S; Holmberg E; Holmén A; Persson B; Sandberg C; Nilbert M Acta Oncol; 2016 Aug; 55(8):993-1000. PubMed ID: 26935355 [TBL] [Abstract][Full Text] [Related]
10. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study. Utjés D; Lyth J; Lapins J; Eriksson H Int J Cancer; 2017 Dec; 141(11):2243-2252. PubMed ID: 28799271 [TBL] [Abstract][Full Text] [Related]
11. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Hoersch B; Leiter U; Garbe C Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427 [TBL] [Abstract][Full Text] [Related]
12. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register. Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C; Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913 [TBL] [Abstract][Full Text] [Related]
14. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry. Huang K; Fan J; Misra S J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196 [TBL] [Abstract][Full Text] [Related]
15. [Survival analysis in patients with cutaneous malignant melanoma]. Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233 [TBL] [Abstract][Full Text] [Related]
16. Is sex an independent prognostic factor in cutaneous head and neck melanoma? Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966 [TBL] [Abstract][Full Text] [Related]
17. A prospective population-based study of cutaneous malignant melanoma of the head and neck. Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review. Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490 [TBL] [Abstract][Full Text] [Related]
19. Stage-specific direct health care costs in patients with cutaneous malignant melanoma. Lyth J; Carstensen J; Synnerstad I; Lindholm C J Eur Acad Dermatol Venereol; 2016 May; 30(5):789-93. PubMed ID: 25807966 [TBL] [Abstract][Full Text] [Related]
20. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision. McKenna DB; Lee RJ; Prescott RJ; Doherty VR Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]